Clinical Trials Browser

Phase EARLY_PHASE1 × INDUSTRY × Interventional × Clear all

NCT07468708 2026-03-12

The Dosimetry, Safety and Diagnostic Efficacy of ⁶⁸Ga-FC516 in Healthy Subjects and Patients With Prostate Cancer

Phase EARLY_PHASE1 Not yet recruiting

Prostatic Neoplasms

NCT07459283 2026-03-10

The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors

Phase EARLY_PHASE1 Not yet recruiting

BreastHead & NeckSarcoma

Breast Neoplasms, Head and Neck Neoplasms, Sarcoma, Thyroid Neoplasms

NCT07274813 2026-03-03

A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX37 in Advanced/Metastatic Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasmThoracic

Advanced/Metastatic Solid Tumors

NCT06305962 2026-02-19

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

Phase EARLY_PHASE1 Recruiting

BreastDermatologicGynecologicHead & NeckThoracic

Turcot syndrome, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Melanoma, Endometrial Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT07412665 2026-02-17

A Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors.

Phase EARLY_PHASE1 Not yet recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT06824155 2026-02-11

RAD202

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

HER2 Gene Mutation

NCT07378436 2026-01-30

A Clinical Study of GK02 in Malignant Ascites

Phase EARLY_PHASE1 Recruiting

Gastrointestinal

Stomach Neoplasms

NCT06653023 2026-01-20

Wondercel-UWD3

Phase EARLY_PHASE1 Recruiting

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Hepatocellular

NCT06662227 2026-01-20

Universal CAR-T Cells (REVO-UWD-19) for Refractory and Relapsed B-Cell Tumors

Phase EARLY_PHASE1 Recruiting

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, B-Cell

NCT06663046 2026-01-20

Universal CAR-T Cells (REVO-UWD-00B) for Refractory and Relapsed Multiple Myeloma

Phase EARLY_PHASE1 Recruiting

Multiple Myeloma

NCT06653010 2026-01-16

Wondercel-UWD1

Phase EARLY_PHASE1 Recruiting

Gastrointestinal

Colorectal Neoplasms

NCT07336823 2026-01-13

JY232(JY232) Injection in Relapsed/Refractory Multiple Myeloma

Phase EARLY_PHASE1 Recruiting

Multiple Myeloma

NCT07316361 2026-01-07

GYNORYLAQ™

Phase EARLY_PHASE1 Enrolling by invitation

Endometrial Neoplasms

NCT07131254 2025-12-30

A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in Adult Participants With Relapsed/Refractory CD19-positive B-cell Malignant Hematological Tumors

Phase EARLY_PHASE1 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms

NCT06645808 2025-12-29

VARTUTRACE

Phase EARLY_PHASE1 Recruiting

BreastCNSGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Chondrosarcoma, Colonic Neoplasms, Esophageal Neoplasms, Glioblastoma, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Sarcoma, Osteosarcoma, Stomach Neoplasms

NCT07205315 2025-12-26

A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia

Phase EARLY_PHASE1 Recruiting

Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Hemolytic, Autoimmune, Burkitt Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell

NCT04960072 2025-12-23

A Study of GC101 TIL in r/r Gastrointestinal Tumors (10hospital)

Phase EARLY_PHASE1 Recruiting

Gastrointestinal

Digestive System Neoplasms

NCT03433898 2025-12-19

This Study Aims to Find a Safe and Effective Dose of BI 754091. The Study Also Aims to Find Safe and Effective Doses of BI 754091 and BI 754111 in Combination. This Study is Done in Asian Patients With Different Types of Cancer

Phase EARLY_PHASE1 Completed

146 enrolled 25 charts

Neoplasms

NCT06488950 2025-12-16

A Study of TIL in Advanced Solid Tumors (DFGD)

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT04943913 2025-12-11

Study of GC101 TIL in Brain Glioma (Soochow2)

Phase EARLY_PHASE1 Recruiting

Glioma

NCT05098171 2025-12-11

A Study of GC201 TIL in Advanced Gynecologic Tumors (10hospital)

Phase EARLY_PHASE1 Recruiting

Advanced Gynecologic Tumors

NCT05098184 2025-12-11

A Study of GC101 TIL in Advanced Melanoma (10hospital)

Phase EARLY_PHASE1 Recruiting

Advanced Melanoma

NCT05098197 2025-12-11

A Study of GC101 TIL in Advanced Hepatobiliary-Pancreatic Cancers (10hospital)

Phase EARLY_PHASE1 Recruiting

Gastrointestinal

Advanced Liver Cancers

NCT05142475 2025-12-11

A Study of GC101 TIL in Advanced Breast Cancer (10hospital)

Phase EARLY_PHASE1 Recruiting

Breast Neoplasms

NCT05468307 2025-12-11

A Study of GC203 TIL in Advanced Gynecologic Tumors (10hospital)

Phase EARLY_PHASE1 Completed

Advanced Gynecologic Tumors

NCT06736275 2025-12-08

A Phase I Study on Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of SXRN Plasmid DNA Technique in Patients With Advanced Solid Tumors

Phase EARLY_PHASE1 Active not recruiting

Cachexia

NCT07077616 2025-12-08

TAMAVAQTM

Phase EARLY_PHASE1 Recruiting

Glioma

NCT07266311 2025-12-05

CAR-T for Claudin18.2 Positive Solid Tumors

Phase EARLY_PHASE1 Not yet recruiting

Other solid neoplasm

Claudin18.2 Positive Advanced Solid Tumors

NCT05021120 2025-12-04

A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK127 in Combination With AK104 in Advanced and Metastatic Solid Tumours

Phase EARLY_PHASE1 Completed

Other solid neoplasm

Advanced or Metastatic Solid Tumours

NCT07246304 2025-11-24

TC-D101 Cell Therapy for Patients With DLL3-Positive SCLC

Phase EARLY_PHASE1 Recruiting

Small Cell Lung Carcinoma

NCT07243366 2025-11-21

Allogeneic CD19-CAR-NK Cells in Patients With Refractory Myasthenia Gravis

Phase EARLY_PHASE1 Not yet recruiting

Myasthenia Gravis

NCT04712721 2025-10-10

Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins.

Phase EARLY_PHASE1 Terminated

Brain Neoplasms, Breast Neoplasms, Glioblastoma

NCT06516510 2025-09-25

A Dosimetry Study of Lutetium (177Lu) rhPSMA-10.1 and Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto®) in Patients With Non-curative Metastatic Prostate Cancer

Phase EARLY_PHASE1 Terminated

Prostatic Neoplasms

NCT05023551 2025-09-16

Study of DSP-0390 in Patients With Recurrent High-Grade Glioma

Phase EARLY_PHASE1 Active not recruiting

Brain Neoplasms, Glioblastoma, Glioma

NCT07166263 2025-09-10

Safety and Efficacy of NK510 to Treat Gastric Cancer and Colorectal Cancer

Phase EARLY_PHASE1 Not yet recruiting

Gastrointestinal

Stomach Neoplasms, Colorectal Neoplasms

NCT06446128 2025-08-21

A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed or Refractory B Cell Non-Hodgkin Lymphoma(NHL)

Phase EARLY_PHASE1 Recruiting

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

NCT05245058 2025-08-17

SPH5030 Tablets in Subjects With Advanced Her2-positive Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

HER2-positive Advanced Solid Tumors

NCT06822998 2025-08-17

HF50

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT07123662 2025-08-14

γδ T Cell Therapy for Relapse Prevention in High-Risk AML Post-Transplant

Phase EARLY_PHASE1 Not yet recruiting

Other hematologic neoplasm

Leukemia

NCT06273852 2025-08-11

A Study of the Intratumoral Microdose Administration of PBA-0405 in Patients With Solid Tumors

Phase EARLY_PHASE1 Completed

BreastHead & Neck

Squamous Cell Carcinoma of Head and Neck, Triple Negative Breast Neoplasms

NCT06700070 2025-08-11

A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors

Phase EARLY_PHASE1 Recruiting

BreastHead & Neck

Squamous Cell Carcinoma of Head and Neck, Triple Negative Breast Neoplasms

NCT07048353 2025-07-02

CAR-T，MTD

Phase EARLY_PHASE1 Not yet recruiting

Lymphoma, Lymphoma, B-Cell

NCT07003178 2025-06-04

A Study to Evaluate the Safety and Clinical Efficacy of STR-P004

Phase EARLY_PHASE1 Not yet recruiting

Lymphoma, Non-Hodgkin

NCT06675513 2025-05-20

Autologous CAR-T Cells (WD-01) for Metastatic Colorectal Cancer

Phase EARLY_PHASE1 Recruiting

Gastrointestinal

Colorectal Neoplasms

NCT04237649 2025-05-18

KAZ954 Alone and With PDR001, NZV930 and NIR178 in Advanced Solid Tumors

Phase EARLY_PHASE1 Terminated

Other solid neoplasm

Solid Tumors

NCT06092047 2025-05-16

UTAA09 Injection in the Treatment of Relapsed/Refractory Hematolymphatic Malignancies.

Phase EARLY_PHASE1 Recruiting

CD19-positive Relapsed or Refractory B-cell Malignancies

NCT06976931 2025-05-16

Study on the Safe Dosage and Therapeutic Effect of the Drug YY2201 Tablets on Patients With Advanced Cancer

Phase EARLY_PHASE1 Not yet recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT06959563 2025-05-13

9vHPV-BCG

Phase EARLY_PHASE1 Active not recruiting

Papillomavirus Infections

NCT06400485 2025-05-02

AMT-676 in Patients With Advanced Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT06797427 2025-03-17

A Study to Assess the Pharmacokinetics of Sorafenib in Mesoporous Magnesium Carbonate (DPH001) Compared to Nexavar® (sorafenib) in Healthy Volunteers

Phase EARLY_PHASE1 Completed

Gastrointestinal

Carcinoma, Hepatocellular